Neuronetics, Inc. (STIM) vs Voyager Therapeutics, Inc. (VYGR)
A side-by-side comparison of Neuronetics, Inc. and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
STIM
Neuronetics, Inc.
$2.21HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VYGR
Voyager Therapeutics, Inc.
$2.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — STIM vs VYGR
growth of $100 · dividends reinvested · last 8ySTIM -92.1% (-27.2%/yr)VYGR -88.7% (-23.9%/yr)VYGR compounded faster over this window
STIM VYGR
STIM vs VYGR: by the numbers
- •STIM is the larger company ($154M vs $149M market cap).
- •Both run net losses; STIM's is the smaller (-19.62% vs -312.63% net margin).
- •STIM grew revenue faster over the past five years (23.26% vs -23.59% CAGR).
Metrics side by side
Valuation
| Metric | STIM | VYGR |
|---|---|---|
| P/S ratio | 0.99 | 4.31 |
| P/B ratio | 8.62 | 0.96 |
Profitability
| Metric | STIM | VYGR |
|---|---|---|
| Gross margin | 49.12% | -227.62% |
| Operating margin | -14.74% | -326.56% |
| Net margin | -19.62% | -312.63% |
| ROE | -170.49% | -69.78% |
| ROIC | -22.15% | -64.72% |
Growth (annualized)
| Metric | STIM | VYGR |
|---|---|---|
| Revenue CAGR (5Y) | 23.26% | -23.59% |
| Total return CAGR (5Y) | -19.46% | -0.08% |
Frequently asked
- Which has grown faster, STIM or VYGR?
- Over the past five years, STIM grew revenue faster — STIM at a 23.26% CAGR versus VYGR at -23.59%.
- How have STIM and VYGR total returns compared?
- Over the past 5 years, STIM delivered -19.46% and VYGR delivered -0.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Neuronetics ROEVoyager Therapeutics ROENeuronetics operating marginVoyager Therapeutics operating marginNeuronetics revenue growthVoyager Therapeutics revenue growthNeuronetics free cash flowVoyager Therapeutics free cash flow
Neuronetics & Voyager Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.